Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma

被引：0
|
作者：
Atanas Pachev
Lucas Raynaud
Luisa Paulatto
Marco Dioguardi Burgio
Vincent Roche
Carmela Garcia Alba
Annie Sibert
Matthieu Lagadec
Juliette Kavafyan-Lasserre
Catherine Paugam-Burtz
Valérie Vilgrain
Maxime Ronot
机构：
[1] Hôpital Beaujon,Department of Radiology, APHP.Nord
[2] INSERM U1149,Department of Anaesthesiology, APHP.Nord
[3] CRI,undefined
[4] Université de Paris,undefined
[5] Hôpital Beaujon,undefined
来源：
European Radiology | 2021年 / 31卷
关键词：
Analgesics, opioid; Liver cirrhosis; Chemoembolization, therapeutic; Pain, measurement; Pain, procedural;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3267 / 3275
页数：8
相关论文
共 50 条
  • [21] Transarterial chemoembolization for hepatocellular carcinoma
    Lau, WY
    Yu, SCH
    Lai, ECH
    Leung, TWT
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (01) : 155 - 168
  • [22] TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
    Vremera, Teodora
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (01): : 182 - 182
  • [23] Fever is not good after transarterial chemoembolization for hepatocellular carcinoma
    Yang, Hung-Chih
    ADVANCES IN DIGESTIVE MEDICINE, 2020, 7 (02) : 56 - 57
  • [24] PLEURITIS AND EMPYEMA AFTER TRANSARTERIAL CHEMOEMBOLIZATION OF HEPATOCELLULAR CARCINOMA
    Channick, Jessica E.
    Brownstein, Adam J.
    Wilcox, Chad S.
    Zhong, Jin
    Hoo, Guy W. Soo
    CHEST, 2022, 162 (04) : 1391A - 1392A
  • [25] Hepatic Decompensation After Transarterial Chemoembolization For Hepatocellular Carcinoma
    Hughes, Dempsey
    Gordon, Fredric D.
    Stuart, Keith E.
    Nugent, F. W.
    Flake, Sebastian
    Simpson, Mary Ann
    Qamar, Amir A.
    HEPATOLOGY, 2015, 62 : 417A - 418A
  • [26] A rare complication after transarterial chemoembolization for hepatocellular carcinoma
    Huang, Y. -S.
    Chang, C. -C.
    Chang, Y. -C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (06) : 487 - 488
  • [27] Predictive factors for the benefit of triple-drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma
    He, MinKe
    Li, Qing
    Shen, JingXian
    Tan, GuoSheng
    Li, QiJiong
    Lai, JiaYing
    Wei, Wei
    Zhang, YaoJun
    Zou, RuHai
    Chen, MinShan
    Guo, RongPing
    Shi, Ming
    CANCER MEDICINE, 2019, 8 (09): : 4200 - 4213
  • [28] Prognostic factors of hepatocellular carcinoma patients treated by transarterial chemoembolization
    Xiao, Jun
    Li, Guojian
    Lin, Shuhan
    He, Ke
    Lai, Hao
    Mo, Xianwei
    Chen, Jiansi
    Lin, Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (03): : 1114 - 1123
  • [29] Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization
    Fako, Valerie
    Martin, Sean P.
    Pomyen, Yotsawat
    Budhu, Anuradha
    Chaisaingmongkol, Jittiporn
    Franck, Sophia
    Lee, Joyce Man-Fong
    Ng, Irene Oi-Lin
    Cheung, Tan-To
    Wei, Xiyang
    Liu, Niya
    Ji, Junfang
    Zhao, Lei
    Liu, Zhaogang
    Jia, Hu-Liang
    Tang, Zhao-You
    Qin, Lun-Xiu
    Kloeckner, Roman
    Marquardt, Jens
    Greten, Tim
    Wang, Xin Wei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (12): : 2654 - 2663
  • [30] Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma
    Langenbach, Marcel C.
    Vogl, Thomas J.
    Said, Gulia
    Scholtz, Jan-Erik
    Hammerstingl, Renate
    Gruber-Rouh, Tatjana
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (03) : 196 - 202
12345